Trial
NCT03149679
The p53 Colorectal Cancer Trial
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Haukeland University Hospital
Collaborators
—
Condition
Colorectal Cancer Metastatic
Intervention
Cyclophosphamide
Why stopped
The study was discontinued after the first pre-planned interim analysis due to insufficient response rates.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-22